Johnson & Johnson Co. (JNJ)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK, NJ 08933

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

Data as of 2021-10-09 08:59:36 -0400
Market Cap423.645 Billion Shares Outstanding2.632 Billion Avg 30-day Volume6.605 Million
P/E Ratio23.84451 Dividend Yield2.55 EPS6.65
Price/Sales4.74 Debt to Equity2.54 EBITDA30.408 Billion
Price to Book Value6.07 Forward PE16.6 Enterprise Value430.611 Billion
Total Cash25.306 Billion Current Debt38.721 Billion Gross Profit59.754 Billion
BETA0.51827 52-week High/Low178.93 / 130.31 Next Earnings Date2021-10-19 Price to Cash FLow (P/CF) 69.304
Data provided by IEX Cloud
View SEC Filings from JNJ instead.

View recent insider trading info

Funds Holding JNJ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding JNJ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HEWSON MARILLYN A

  • Director
3,820 2021-09-07 5

WASHINGTON A. EUGENE

  • Director
25,208 2021-09-07 5

WEINBERGER MARK A

  • Director
3,872 2021-09-07 5

GORSKY ALEX CHAIRMAN, CEO

  • Officer
  • Director
477,885 2021-02-12 2

FASOLO PETER EXEC VP, CHIEF HR OFFICER

  • Officer
107,343 2021-02-12 2

ULLMANN MICHAEL H EXEC VP, GENERAL COUNSEL

  • Officer
152,911 2021-02-12 2

STOFFELS PAULUS VICE CHAIR, EXEC COMMITTEE

  • Officer
275,547 2021-02-12 2

DUATO JOAQUIN VICE CHAIR, EXEC COMMITTEE

  • Officer
196,791 2021-02-12 2

WOLK JOSEPH J EXEC VP, CFO

  • Officer
24,949 2021-02-12 2

MCEVOY ASHLEY EVP, WW CHAIR, MEDICAL DEVICES

  • Officer
32,951 2021-02-12 2

TAUBERT JENNIFER L EVP, WW CHAIR, PHARMACEUTICALS

  • Officer
115,126 2021-02-12 2

SNEED MICHAEL E EVP, GLOBAL CORP AFF & CCO

  • Officer
66,060 2021-02-12 3

WENGEL KATHRYN E EVP, CHIEF GSC OFFICER

  • Officer
64,742 2021-02-12 2

MONGON THIBAUT EXEC VP, WW CHAIR, CONSUMER

  • Officer
39,585 2021-02-12 2

DECKER ROBERT J CONTROLLER, CAO

  • Officer
14,890 2021-02-12 2

WILLIAMS RONALD A

  • Director
0 2021-02-09 1

MULCAHY ANNE M

  • Director
0 2021-02-09 1

PRINCE CHARLES

  • Director
0 2021-02-09 1

DAVIS D SCOTT

  • Director
0 2021-02-09 1

JOLY HUBERT

  • Director
0 2021-02-09 1

DAVIS IAN

  • Director
0 2021-02-09 1

BECKERLE MARY C

  • Director
0 2021-02-09 1

MCCLELLAN MARK B.

  • Director
0 2021-02-09 1

DOUDNA JENNIFER A

  • Director
0 2021-02-09 1

WEST NADJA

  • Director
0 2021-02-09 2

PEREZ WILLIAM D

  • Director
16,030 2020-03-13 0

MESQUITA JORGE S. EXEC VP, WW CHAIR, CONSUMER

  • Officer
27,344 2019-02-08 0

KAPUSTA RONALD A CONTROLLER, CAO

  • Officer
18,522 2019-02-08 0

PETERSON SANDRA E EXEC VP, GROUP WW CHAIRMAN

  • Officer
83,349 2018-02-12 0

CARUSO DOMINIC J EXEC VP, FINANCE; CFO

  • Officer
171,986 2018-02-12 0

PRUDEN GARY J EXEC VP, WW CHAIR, MED DEVICES

  • Officer
43,726 2017-02-28 0

LINDQUIST SUSAN L

  • Director
0 2016-09-06 0

COLEMAN MARY SUE

  • Director
11,952 2016-02-08 0

CULLEN JAMES

  • Director
0 2015-02-09 0

COSGROVE STEPHEN J CORPORATE CONTROLLER

  • Officer
0 2015-02-09 0

MULLIN LEO F

  • Director
0 2015-02-09 0

JOHNS MICHAEL M E

  • Director
15,290 2014-02-10 0

SATCHER DAVID

  • Director
15,393 2013-02-11 0

WELDON WILLIAM C

  • FORMER CHAIRMAN OF THE BOARD
No longer subject to file 2013-02-08 0

DEYO RUSSELL C VP, GENERAL COUNSEL

  • Officer
No longer subject to file 2012-02-22 0

MCCOY SHERILYN S MEMBER, EXECUTIVE COMMITTEE

  • Officer
81,370 2012-02-09 0

GOGGINS COLLEEN A MEMBER, EXECUTIVE COMMITTEE

  • Officer
109,043 2011-01-10 0

LANGBO ARNOLD G

  • Director
10,190 2010-03-09 0

FOSTER-CHEEK KAYE I VP, HUMAN RESOURCES

  • Officer
5,797 2009-12-31 0

VALERIANI NICHOLAS J VP, STRATEGY & GROWTH

  • Officer
  • Director
  • MEMBER, EXECUTIVE COMMITTEE
67,429 2009-09-30 0

CASEY DONALD M JR. MEMBER, EXECUTIVE COMMITTEE

  • Officer
44,960 2009-09-10 0

POON CHRISTINE A VICE CHAIRMAN

  • Officer
  • Director
55,889 2009-02-12 0

SCODARI JOSEPH C

  • RETIRED EXEC COMMITTEE MEMBER
No longer subject to file 2008-05-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

WASHINGTON A. EUGENE - Director

2021-09-09 16:37:50 -0400 2021-09-07 A 323 $174.53 a 25,208 direct

WEINBERGER MARK A - Director

2021-09-09 16:37:59 -0400 2021-09-07 A 223 $174.53 a 3,872 direct

HEWSON MARILLYN A - Director

2021-09-09 16:37:44 -0400 2021-09-07 A 194 $174.53 a 3,820 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
JOHNSON & JOHNSON JNJ 2021-10-15 22:15:04 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 21:45:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 21:15:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 20:45:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 20:15:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 19:45:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 19:15:04 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 18:45:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 18:15:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 17:45:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 17:15:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 16:45:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 16:15:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 15:45:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 15:15:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 14:45:02 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 14:15:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 13:45:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 13:15:03 UTC -0.18 0.25 0
JOHNSON & JOHNSON JNJ 2021-10-15 12:45:03 UTC -0.18 0.25 0

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Ultimus Managers Trust- WAYCROSS LONG/SHORT EQUITY FUND JNJ -5300.0 shares, $-813073.0 2020-08-31 N-PORT
Waycross Independent Trust- WAYCROSS LONG/SHORT EQUITY FUND JNJ -5300.0 shares, $-897025.0 2021-05-31 N-PORT
JPMorgan Trust I- JPMorgan Research Market Neutral Fund JNJ -3053.0 shares, $-525726.6 2021-07-31 N-PORT

Elevate your investments